Please assess the completion status of the following clinical trial:

Trial Title: A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: None
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with T2DM who are not receiving treatment with any anti-hyperglycemic agents (AHAs) for at least 12 weeks, or who are receiving treatment with a stable dose and regimen of metformin monotherapy for at least 12 weeks and have a hemoglobin A1c (HbA1c) in the range of \>=7% to \<=10%~Exclusion Criteria:~* History of Type 1, brittle diabetes or secondary forms of diabetes~* History of 1 or more severe hypoglycemic episodes~* History of diabetic complications considered to be clinically significant by the Investigator~* History of or current illness considered to be clinically significant by the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Part 1: no Intervention (Type: NO_INTERVENTION): In Part 1 of the study, patients will not receive any study drug.
- Part 2: canagliflozin (Type: EXPERIMENTAL): In Part 2 of the study, patients will receive canagliflozin once daily on Days 1 through 8.

Based on this trial design, predict the completion outcome and termination type (if applicable).